+499.5%
MRNA vs NSC
+20.4%
+479.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NSC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.5% | -2.7% | -2.6% |
| 7D | +5.5% | -5.5% | +11.0% | +10.3% |
| 30D | +158.7% | -3.2% | +161.9% | +166.4% |
| 3M | +182.1% | +7.7% | +174.5% | +183.5% |
| 6M | +151.8% | +4.5% | +147.3% | +161.3% |
| YTD | +393.6% | +15.6% | +378.0% | +359.2% |
| 1Y | +499.5% | +19.8% | +479.6% | +440.0% |
| All | +499.5% | +20.4% | +479.1% | +440.0% |
Cumulative growth
Daily Returns
Daily percentage return beside NSC.
Daily Out/Under-Performance
Portfolio return minus NSC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NSC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NSC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling